Delivery Order SPE2DB22D3301-SPE2DB25FY5TW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a contract ceiling value of $1,614.06. This is a non-set-aside, competitively awarded delivery order that will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 13, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, a hormonal contraceptive product. This firm fixed price delivery order, valued at $2,690.10, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract requires performance and completion by May 13, 2025, with fulfillment from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, a contraceptive medical device. This competitively awarded, non-set-aside delivery order has a ceiling value of $2,152.08 with a firm fixed price structure and an ultimate completion date of September 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,345.05 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed-price contract with an ultimate completion date of August 8, 2025. This non-set-aside delivery order was competitively awarded and represents a pharmaceutical supply fulfillment within the company's broader federal contracting portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed price delivery order was awarded without set-aside consideration and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the DLA. The contraceptive product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a ceiling value of $1,165.71. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol (EE) vaginal rings. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 21, 2025. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY5TWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,703.65 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings on June 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of June 5, 2025. This delivery order exemplifies AmerisourceBergen's critical role as a major pharmaceutical distributor within the federal medical supply chain, particularly supporting Defense Health Agency and military healthcare systems. The company's substantial IDC with DLA Troop Support Medical serves as a comprehensive global pharmaceutical support vehicle, enabling the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its capacity to fulfill diverse medical procurement requirements through open competition, ranging from small-value transactions to substantial orders, positioning the company as a key vendor for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/4/25 |